CLINICAL_TRIALS
research
· 2025-04-30
Clinical Trial Update: Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial is evaluating dose-escalated stereotactic ablative radiotherapy (SABR) for metastases in the spine from solid tumors, and is currentl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cancer Trials Ireland | Conditions: Solid Tumor Spine Metastases | Phase 1, Phase 2 | Status: RECRUITING